IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announced ...

and the failure to introduce new products and services in a timely manner or at competitive prices to compete successfully against competitors; disruptions in relationships with Envoy ...

Gross profit for the three months ended September 30, 2024 decreased by $287 thousand, or 2%, to $11.8 million, from $12.0 ...